Editorial
Welcome to the March edition of i2P – Information to Pharmacists.
You may have noiticed if you receive i2P by email, that we have simplified our mail out presentation.
This was because the code in our earlier version appeared to be too unstable to maintain, hence the simpler presentation.
Columns
Rollo Manning: Pharma-Goss
John Dunlop: Inside NZ
Loretta Marron BSc: Health Watch
Barry Urquhart: Marketing Focus
Harvey Mackay: Strategic Thinking
Mark Neuenschwander: I`ve been thinking about...Recent Comments
Past Editions
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Pharma News
Staff Writer: SIGMA Pharmaceuticals suspends share trading before release of revised earnings outlookHospital News
Health Politics
Pat Gallagher: Health Informatics - The State of the Nation
Peter Sayers: The Three-Ring Circus
Dr David More: e-Health IdentifiersEPublications
Read This First
I2P E-Magazine
The following is a list of suggestions to help you get the most out of the i2P resources on site.
Do not hesitate to communicate with us if you have any enquiry or a suggestion for us to produce a better product.
* Forward your initial email summary received to a range of your colleagues who would be interested in reading i2P E-Magazine.
* Once you are on the site, please use the "Send to a friend" link to pass on valuable information to colleagues and friends.
* Always check that your email filters are set to be "friendly" for i2P deliveries.
Even if you are receiving i2P without problem, still set your filters, because Internet providers can change filter settings or ban specific fileservers if they are unfortunate enough to host a totally unrelated publication that may have been placed on someone's banned list.
If you are having difficulties, please let us know and we will assist you.
* Get adventurous and use new technology in the form of an RSS reader and continually access i2P through importing the RSS link on the home page of the i2P website. If you don't have an RSS reader, get one free at: http://www.feedreader.com/download
* Please feel free to comment on any article by sending an email to the editor neilj@computachem.com.au
* Encourage colleagues to subscribe online at the i2P home page subscription panel.
* Always let us know if you have a particular topic you would like covered.
* Letters to the editor are always encouraged - but there is an alternative at the foot of each article - the "comments" link. This will enable you to comment on any article immediately after reading.
* You can also share interesting material through a range of social links now included as standard for i2P.
* Our archives are open for use as a reference source.
There is an enormous range of contemporary pharmacy content available for students, researchers or business planners.
* Pharmacy organisations - commercial and professional - are invited to contribute news items for publication.
Just simply email the editor at neilj@computachem.com.au with your item, preferably as a Word document and with jpeg graphics separately.
* Readers are reminded that the views expressed by each writer are their own and not necessarily those of the editor, or i2P associated staff.
* Please report any broken links or distorted formatting to neilj@computachem.com.au
* If there is any distortion of text or graphics in your view, please click on this link
http://www.i2p.com.au (best viewed in Internet Explorer 7 or greater or Firefox 2 or greater with minimum desktop resolution of 1024 pixels.
Dr Andrew Byrne & Associates: Fatal torsade tachycardia due to methadone either rare or non-existent finds Norwegian study
Neil Retallick: A time of pivotal change will require new ways of thinking about community pharmacy
Neil Johnston: Dispensing errors and criminality
